Oncology Institute Company Top Insiders

Oncology Institute Management Team Effectiveness

The company has Return on Asset of (0.1766) % which means that on every $100 spent on assets, it lost $0.1766. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (2.7762) %, meaning that it generated no profit with money invested by stockholders. Oncology Institute's management efficiency ratios could be used to measure how well Oncology Institute manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.45. The current Return On Capital Employed is estimated to decrease to -0.52. As of now, Oncology Institute's Other Current Assets are increasing as compared to previous years. The Oncology Institute's current Debt To Assets is estimated to increase to 0.75, while Non Currrent Assets Other are projected to decrease to under 377.6 K. The Oncology Institute's current Common Stock Shares Outstanding is estimated to increase to about 76 M. The Oncology Institute's current Net Income Applicable To Common Shares is estimated to increase to about 64.3 K

Oncology Institute Workforce Comparison

Oncology Institute Profit Margins

The company has Net Profit Margin of (0.16) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.09) %, which entails that for every $100 of revenue, it lost $0.09.

Oncology Institute Insider Trading History

Oncology Institute Notable Stakeholders

The success or failure of an entity such as Oncology Institute often depends on how effective the management is. Oncology Institute management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Oncology management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Oncology management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Oncology Institute's price analysis, check to measure Oncology Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncology Institute is operating at the current time. Most of Oncology Institute's value examination focuses on studying past and present price action to predict the probability of Oncology Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncology Institute's price. Additionally, you may evaluate how the addition of Oncology Institute to your portfolios can decrease your overall portfolio volatility.